Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Editorial

Clinical impact of five cardiometabolic risk factors in metabolic dysfunction-associated steatotic liver disease (MASLD): Insights into regional and ethnic differences

Joo Hyun Oh, Dae Won Jun

Clin Mol Hepatol. 2024;30(2):168-170. Published online March 5, 2024

DOI: https://doi.org/10.3350/cmh.2024.0140

View: 967 Download: 28 Crossref: 1

Review

Causes and risk profiles of mortality among individuals with nonalcoholic fatty liver disease

Peter Konyn, Aijaz Ahmed, Donghee Kim

Clin Mol Hepatol. 2023;29(Suppl):S43-S57. Published online November 22, 2022

DOI: https://doi.org/10.3350/cmh.2022.0351

View: 3540 Download: 152 Web of Science: 13 Crossref: 13

Correspondence

Correspondence on Letter regarding “Risk factors in nonalcoholic fatty liver disease”

Eileen L. Yoon, Dae Won Jun

Clin Mol Hepatol. 2023;29(4):1050-1051. Published online August 29, 2023

DOI: https://doi.org/10.3350/cmh.2023.0310

View: 1299 Download: 34

Special Review

Waiting for the changes after the adoption of steatotic liver disease

Eileen L. Yoon, Dae Won Jun

Clin Mol Hepatol. 2023;29(4):844-850. Published online September 6, 2023

DOI: https://doi.org/10.3350/cmh.2023.0291

View: 1959 Download: 160 Web of Science: 4 Crossref: 11

Editorial

Non-obese or lean nonalcoholic fatty liver disease matters, but is it preventable or inevitable in light of its risk factors?

Heejoon Jang, Won Kim

Clin Mol Hepatol. 2023;29(2):381-383. Published online March 9, 2023

DOI: https://doi.org/10.3350/cmh.2023.0088

View: 2501 Download: 75 Web of Science: 2 Crossref: 2

Letter to the Editor

Correspondence on Letter regarding “Impacts of muscle mass dynamics on prognosis of outpatients with cirrhosis”

Tae Hyung Kim, Young Kul Jung, Hyung Joon Yim

Clin Mol Hepatol. 2023;29(1):173-175. Published online November 15, 2022

DOI: https://doi.org/10.3350/cmh.2022.0372

View: 2561 Download: 41 Web of Science: 1 Crossref: 1

Original Article

Outcomes after liver transplantation in Korea: Incidence and risk factors from Korean transplantation registry

Jong Man Kim, Deok Gie Kim, Jihyun Kim, Keunsung Lee, Kwang-Woong Lee, Je Ho Ryu, Bong-Wan Kim, Dong Lak Choi, Young Kyoung You, Dong-Sik Kim, Yang Won Nah, Koo Jeong Kang, Jai Young Cho, Geun Hong, Hee Chul Yu, Ju Ik Moon, Dongho Choi, Shin Hwang, Myoung Soo Kim

Clin Mol Hepatol. 2021;27(3):451-462. Published online February 2, 2021

DOI: https://doi.org/10.3350/cmh.2020.0292

View: 6852 Download: 309 Web of Science: 31 Crossref: 33

Special topic: Alcoholic liver diseases The 14th International Symposium on Alcoholic Liver and Pancreatic Diseases and Cirrhosis (ISALPDC)

Alcohol and hepatocarcinogenesis

Makiko Taniai

Clin Mol Hepatol. 2020;26(4):736-741. Published online October 1, 2020

DOI: https://doi.org/10.3350/cmh.2020.0203

View: 6064 Download: 175 Web of Science: 23 Crossref: 21

Review

Factors affecting drug-induced liver injury: antithyroid drugs as instances

Reza Heidari, Hossein Niknahad, Akram Jamshidzadeh, Narges Abdoli

Clin Mol Hepatol. 2014;20(3):237-248. Published online September 25, 2014

DOI: https://doi.org/10.3350/cmh.2014.20.3.237

View: 17008 Download: 327 Web of Science: 37 Crossref: 42

Original Article

Predictive factors that influence the survival rates in liver cirrhosis patients with spontaneous bacterial peritonitis

Pei Chuan Tsung, Soo Hyung Ryu, In Hye Cha, Hee Won Cho, Jin Nam Kim, You Sun Kim, Jeong Seop Moon

Clin Mol Hepatol. 2013;19(2):131-139. Published online June 27, 2013

DOI: https://doi.org/10.3350/cmh.2013.19.2.131

View: 8767 Download: 93 Crossref: 31

Current status of Liver diseases in Korea: Hepatocellular carcinoma

Il Han Song , Kyung Sik Kim

Clin Mol Hepatol. 2009;15(60):50-59. Published online December 31, 2009

DOI: https://doi.org/10.3350/kjhep.2009.15.S6.S50

View: 6061 Download: 49 Crossref: 41

3

Risk factors for early recurrence after surgical resection for hepatocellular carcinoma

Ui Jun Park, M.D., Yong Hoon Kim, M.D., Koo Jeong Kang, M.D., Tae Jin Lim, M.D.

Clin Mol Hepatol. 2008;14(3):371-380. Published online September 30, 2008

DOI: https://doi.org/10.3350/kjhep.2008.14.3.371

View: 5040 Download: 52 Crossref: 12

Natural history of gastric varices and risk factors for bleeding

Choong Hyeon Lee, M.D., Joon Hyoek Lee, M.D., Ph.D., Yong Sung Choi, M.D., Seung Woon Paik, M.D., Dong Hyun Sinn, M.D., Choon Young Lee, M.D., Kwang Cheol Koh, M.D., Geum-Youn Gwak, M.D., Moon Seok Choi, M.D., Byung Chul Yoo, M.D.

Clin Mol Hepatol. 2008;14(3):331-341. Published online September 30, 2008

DOI: https://doi.org/10.3350/kjhep.2008.14.3.331

View: 4785 Download: 66 Crossref: 12

7

The Korean Journal of Serum Hepatitis B Virus DHA Level and Hepatocellulor Carcinoma

Seong Gyu Hwang

Clin Mol Hepatol. 2006;12(4):583-586. Published online January 1, 1970

View: 2359 Download: 15

3

Risk Factors of Morbidity and Mortality Following Surgical Resection for Hepatocellular Carcinoma

Wan Wook Kim, M.D., Kwang-Woong Lee, M.D., Sung Ho Choi, M.D., Jin Seok Heo, M.D., Yong Il Kim, M.D., Sung Ju Kim, M.D., Dae Sung Lee, M.D., Hwan Hyo Lee, M.D., Seung Woon Paik, M.D. Kwang Cheol Koh, M.D. Joon Hyoek Lee, M.D. Moon Seok Choi, M.D. , Byung Chul Yoo, M.D. and Jae Won Joh, M.D.

Clin Mol Hepatol. 2004;10(1):51-61. Published online January 1, 1970

View: 2816 Download: 19

Establishment of Individual Prediction Model According to Risk Factorsfor Development of Hepatocellular Carcinoma in Korea : Establishment of Individual Prediction Model for Hepatocellular Carcinoma

Jae Youn Cheong, M.D., Kwang-Hyub Han, M.D., Dong Kee Kim, Ph.D.*, Sang Hoon Ahn, M.D., Ki Jun Song, M.S.*, Yong Han Paik, M.D., Chang Hwan Choi, M.D., Hyun Woong Lee, M.D., Young Soo Park, M.D., Chae Yoon Chon, M.D., and Young Myoung Moon, M.D.,

Clin Mol Hepatol. 2001;7(4):449-458. Published online January 1, 1970

View: 2191 Download: 18

1 |

Viewed By 5188	Prognostic value of ultra-low-pass whole-genome sequencing of circulating tumor DNA in hepatocellular carcinoma under systemic treatment
Viewed By 5051	MAFLD: How is it different from NAFLD?
Viewed By 5000	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 3680	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Viewed By 3645	Global incidence and prevalence of nonalcoholic fatty liver disease

Cited By 114	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 103	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Cited By 76	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 65	Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach
Cited By 51	MAFLD: How is it different from NAFLD?

Search